BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bumanlag IM, Jaoude JA, Rooney MK, et al. (2022) Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations. Seminars in Radiation Oncology. 32: 125-134 |
Patel RR, Parisi R, Verma V, et al. (2022) Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers. 14 |
Abi Jaoude J, Thunshelle CP, Kouzy R, et al. (2021) Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Advances in Radiation Oncology. 6: 100763 |
Corrigan KL, Kry S, Howell RM, et al. (2021) The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology |
Abi Jaoude J, Kouzy R, Rooney M, et al. (2021) Impact factor and citation metrics in phase III cancer trials. Oncotarget. 12: 1780-1786 |
Fokas E, Appelt A, Glynne-Jones R, et al. (2021) International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nature Reviews. Clinical Oncology |
Metzger AL, Kusi Appiah A, Wright CM, et al. (2021) Financial Relationships Between Industry and Principal Investigators of United States Cooperative Group Randomized Cancer Clinical Trials. International Journal of Cancer |
Abi Jaoude J, Kouzy R, Ghabach M, et al. (2021) Food and Drug Administration approvals in phase 3 Cancer clinical trials. Bmc Cancer. 21: 695 |
Pasalic D, Fuller CD, Mainwaring W, et al. (2021) Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials. Mayo Clinic Proceedings. 96: 420-426 |
De B, Kaiser KW, Ludmir EB, et al. (2020) Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncologica (Stockholm, Sweden). 1-4 |